Clinical Trial Update: To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]

View source ↗

Summary

A Phase 1 study by AstraZeneca evaluated the safety, tolerability, PK and PD of AZD1656 in Japanese patients with Type 2 diabetes mellitus; the trial has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED